Neon Therapeutics is a clinical-stage immuno-oncology company and a leader in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. For more information, please visit https://neontherapeutics.com/ and follow us on Twitter @Neon_Tx.
View Top Employees from Neon Therapeutics| Website | http://www.neontherapeutics.com |
| Ticker | NTGN |
| Revenue | $4.8 million |
| Funding | $161 million |
| Employees | 21 (21 on RocketReach) |
| Founded | 2015 |
| Address | 40 Erie St, Cambridge, Massachusetts 02139, US |
| Phone | (617) 337-4701 |
| Technologies |
JavaScript,
Slack,
Zoom
+8 more
(view full list)
|
| Industry | Organizations, Education, Biotechnology Research, Health Care, Neoantigens, Medical, Cancer vaccines, Therapeutics, T cell therapies, Immune monitoring, Bioinformatics, Epitope selection |
| Web Rank | 4 Million |
| Keywords | Neon Therapeutics, Immuno Oncology Clinical Trial Collaborations, Neon Therapeutics Careers, Ntgn, Neoantigen Licensing Deal |
| Competitors | ARMO BioSciences, Arcus Biosciences, Biosceptre International Limited, Kiromic Biopharma, Inc., PsiOxus |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular Neon Therapeutics employee's phone or email?
Neon Therapeutics Questions
The Neon Therapeutics annual revenue was $4.8 million in 2024.
21 people are employed at Neon Therapeutics.
Neon Therapeutics is based in Cambridge, Massachusetts.
The NAICS codes for Neon Therapeutics are [54, 5417, 541].
The SIC codes for Neon Therapeutics are [873, 87].
Top Neon Therapeutics Employees
-
35+
-
ViewChristina Kuksin
Group Leader, Molecular Immunology at Neon Therapeutics
Boston, Massachusetts, United States25 -
1
-
View
Tamara Davenne
Principal Scientist, Biology lead at Neon Therapeutics
Seneffe, Wallonie, Belgium31 -
1
Related Companies
